Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronen Shemesh

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Infectious Diseases|March 16, 2013
A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenesGirish Ramachandran, Mohan E Tulapurkar, Kristina M Harris, et al.
The Journal of Biological Chemistry|October 16, 2008
Discovery and validation of novel peptide agonists for G-protein-coupled receptorsRonen Shemesh, Amir Toporik, Zurit Levine, et al.
Nature Biotechnology|July 20, 2004
Systematic identification of abundant A-to-I editing sites in the human transcriptomeErez Y Levanon, Eli Eisenberg, Rodrigo Yelin, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 22, 2008
A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effectsIris Hecht, Jiang Rong, André L F Sampaio, et al.
The Journal of Infectious Diseases|October 12, 2014
CD28 homodimer interface mimetic peptide acts as a preventive and therapeutic agent in models of severe bacterial sepsis and gram-negative bacterial peritonitisGirish Ramachandran, Raymond Kaempfer, Chun-Shiang Chung, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Infectious Diseases|March 16, 2013
A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenesGirish Ramachandran, Mohan E Tulapurkar, Kristina M Harris, et al.
The Journal of Biological Chemistry|October 16, 2008
Discovery and validation of novel peptide agonists for G-protein-coupled receptorsRonen Shemesh, Amir Toporik, Zurit Levine, et al.
Nature Biotechnology|July 20, 2004
Systematic identification of abundant A-to-I editing sites in the human transcriptomeErez Y Levanon, Eli Eisenberg, Rodrigo Yelin, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 22, 2008
A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effectsIris Hecht, Jiang Rong, André L F Sampaio, et al.
The Journal of Infectious Diseases|October 12, 2014
CD28 homodimer interface mimetic peptide acts as a preventive and therapeutic agent in models of severe bacterial sepsis and gram-negative bacterial peritonitisGirish Ramachandran, Raymond Kaempfer, Chun-Shiang Chung, et al.
Pageof 2